Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2241292.
- Also identified by PMC identifier 1004213.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 22 year old woman presented with lupus nephritis, hypertension, and intractable nephrotic syndrome. Albumin and furosemide given intravenously was ineffective. Captopril administered in a daily dose of 62.5 mg was associated with a reduction in proteinuria from 28 g/24 hours to 11.5 g/24 hours over 10 weeks, resulting in a weight reduction of 16 kg. This was achieved with relative preservation of renal function. Captopril should be considered in the treatment of intractable proteinuria in patients with lupus nephritis, or when cytotoxic drugs are refused, because of its efficacy and relative safety. Captopril should, however, be used as an adjunct and not as a substitute for standard treatment.
Medical subject headings
- Captopril
- Lupus Nephritis
- Nephrotic Syndrome
- Proteinuria